RecruitingNCT07413185

Relationship Between the Severity of Sleep Deprivation in the First 48 Hours Postpartum, Breastfeeding Motivation, and Breastfeeding Success


Sponsor

Acibadem University

Enrollment

167 participants

Start Date

Mar 12, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

The postpartum period is a critical time marked by significant physiological and psychosocial changes that can affect sleep, emotional well-being, and breastfeeding behaviors. Previous studies indicate that mode of delivery and sleep quality are closely associated with breastfeeding outcomes, with cesarean birth often linked to poorer sleep and lower breastfeeding success. Evidence also suggests that postpartum sleep disturbances are related to reduced breastfeeding self-efficacy, lower motivation, fatigue, depressive symptoms, and shorter breastfeeding duration. However, the literature lacks studies that evaluate insomnia severity, breastfeeding motivation, and breastfeeding success simultaneously-particularly during the first 48 hours after birth. This analytical study aims to assess insomnia severity, breastfeeding motivation, and breastfeeding success (LATCH) within the first 48 postpartum hours and to examine the relationships among these variables. Findings are expected to support early postpartum clinical interventions to improve maternal and infant health outcomes.


Eligibility

Sex: FEMALEMin Age: 18 Years

Inclusion Criteria4

  • Primiparous or multiparous women aged 18 years and older
  • Having a healthy term delivery
  • Infant not admitted to the neonatal intensive care unit (NICU)
  • Initiated breastfeeding within the first 48 hours postpartum

Exclusion Criteria3

  • Complications requiring sedation
  • Severe postpartum hemorrhage
  • Severe postoperative pain or need for narcotic analgesics

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Acibadem Health Group

Istanbul, Altunizade, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07413185


Related Trials